Results 121 to 130 of about 948 (174)

Asfotase alfa has a limited effect in improving the bowed limbs in perinatal benign hypophosphatasia: A case report. [PDF]

Clin Pediatr Endocrinol, 2021
Matsushita M, Mishima K, Nagata T, Kamiya Y, Imagama S, Kitoh H.   +5 more
europepmc   +1 more source

Visualization of asfotase alfa-binding to sites of calcification in vivo

Bone Reports, 2020
Flavia Amadeu de Oliveira, Sonoko Narisawa, Massimo Bottini, José Luis Millán   +3 more
doaj   +1 more source

Adult Hypophosphatasia in a Middle-Aged Patient With Recurrent Fractures: Prevention of New Fractures With Asfotase Alfa. [PDF]

JCEM Case Rep
Inoue R, Ishizawa K, Takamura Y, Kosokabe F, Takeuchi K, Inoue D.   +5 more
europepmc   +1 more source

Prenatal asfotase alfa-mediated enzyme replacement therapy restores delayed calcification in a severe infantile form of hypophosphatasia model mice [PDF]

, 2023
Hasegawa, A, Ichinohe, T, Ishizuka, S, Kasahara, M, Koshika, K, Nakamura-Takahashi, A, Umezawa, A, Yoshida, K   +7 more
core   +1 more source

Change in fracture rate and healthcare resource utilization among patients with hypophosphatasia following initiation of asfotase alfa: a retrospective US claims database analysis. [PDF]

JBMR Plus
Lyons G, Bates T, Vlasnik J, Wakeford C, Donckels EA, Chan PK, Robinson SB, Dahir KM.   +7 more
europepmc   +1 more source

Key Learnings from Clinical Research and Real-World Evidence on Asfotase Alfa Effectiveness in Hypophosphatasia: 10 Years Post-Approval. [PDF]

Adv Ther
Khan AA, Rush ET, Wakeford C, Staub D, Brandi ML.   +4 more
europepmc   +1 more source

Odontohypophosphatasia treated with asfotase alfa enzyme replacement therapy in a toddler: a case report. [PDF]

Clin Pediatr Endocrinol, 2020
Takagi M, Kato S, Muto T, Sano Y, Akiyama T, Takagi J, Okumura A, Iwayama H.   +7 more
europepmc   +1 more source

Long-Term Outcomes of Early Enzyme Replacement Therapy With Asfotase Alfa in Perinatal Benign Hypophosphatasia: Amelioration of Bone Deformities in a Young Child. [PDF]

Cureus
Terayama S, Kobayashi M, Suemitsu T, Samura O, Oishi K.   +4 more
europepmc   +1 more source

AN ADJUNCTIVE USE OF ASFOTASE ALFA AND ZOLEDRONIC ACID AFTER SPINAL SURGERY IN NEUROFIBROMATOSIS TYPE 1 RELATED DYSTROPHIC SCOLIOSIS. [PDF]

AACE Clin Case Rep, 2020
Harindhanavudhi T, Takahashi T, Petryk A, Polly DW.   +3 more
europepmc   +1 more source

Longitudinal course of circulating miRNAs in a patient with hypophosphatasia and asfotase alfa treatment: a case report. [PDF]

JBMR Plus
Hadzimuratovic B, Haschka J, Hackl M, Diendorfer AB, Mittelbach A, Feurstein J, Zwerina J, Resch H, Kocijan R.   +8 more
europepmc   +1 more source